As a professional gynecologic oncologist, I have not been practicing for a long time. Since I was assigned to the Department of Gynecologic Oncology in Shaanxi Cancer Hospital seven years ago, I have seen a variety of patients with gynecologic tumors, benign, malignant, primary and recurrent. Among them, the patients I am most reluctant to see are those who have already failed to be treated in multiple hospitals. Why? There is always a sense of regret in it. Why didn’t they come for treatment earlier? Why do you have to wait until you spend a lot of money before you remember the oncology hospital? Why do we have to delay until we really have no choice before we remember oncology specialties? In the final analysis, it is because the people do not understand and understand the diagnosis and treatment of tumor. First of all, it should be emphasized that gynecological tumors are not terrible, and early diagnosis and treatment are the key. As long as most cancers are detected at an early stage and can receive timely and correct treatment, they may have a cure rate of about 90%. Even at the middle stage, some cancer patients can have a long survival period after reasonable comprehensive treatment. For example, the 5-year survival rate of cervical cancer is over 90% for stage I, 70%-75% for stage II, 40%-50% for stage III, and only about 10% for stage IV. The overall 5-year survival rate is 50%~55%. Due to anatomical and biological characteristics of endometrial cancer, endometrial cancer is characterized by slow growth, late metastasis and early dissemination and more obvious symptoms, so it is diagnosed early. Because of the simpler method of diagnosis, most patients are diagnosed as clinical stage I at the time of consultation. Among gynecologic malignancies, the overall 5-year survival rate is about 70%, and the 5-year survival rate of clinical stage I can be more than 85%. Even for ovarian cancer, the most dangerous gynecologic tumor, the 5-year survival rate of early stage patients, especially those whose tumors are still confined to one or both ovaries, is over 90%. This indicates that if gynecological tumors can be detected, diagnosed and treated early, the outcome is ideal and the prognosis is better. Secondly, gynecological tumors are not scary, but the first diagnosis and treatment is the key. Whether the treatment method is appropriate or not directly affects the prognosis of gynecological tumor patients. For early-stage cervical cancer alone, the choice of surgical method is a problem that clinicians often encounter, as the saying goes: the difference between a hair and a thousand miles. (1) For young patients with CIN grade II-III who need to preserve their reproductive function, “cervical circumcision (LEEP knife)” or “conical hysterectomy” is appropriate; (2) For patients with in situ cancer with clear diagnosis who do not need to preserve the uterus, “extended extra-fascial total hysterectomy” is appropriate. (2) For patients with carcinoma in situ who have a clear diagnosis and do not require preservation of the uterus, an “extended extra-fascial total hysterectomy” is sufficient. The scope of resection is guaranteed to be outside the cervical fascia, complete removal of the patient area, opening the tunnel if necessary, freeing the ureter, with the cutting edge about 1cm beyond the lesion and 1-2cm from the vaginal wall; (3) for patients with cervical cancer la1 stage, “subextensive hysterectomy” is performed. The basic steps are the same as those in (2), but the key to achieve the requirements of this procedure is to cut the ureteral tunnel, separate the ureter laterally, and then perform excision of the cervix and vaginal wall, and pay attention to preserving the nutrient vessels of the ureter. (4) For patients with cervical cancer stage Ia2 to IIa, “extensive hysterectomy + pelvic lymph node dissection” is adopted. This is the basic surgical treatment for cervical cancer. The key operation is to remove all regional lymph nodes and perform extensive total hysterectomy, the latter must open the lateral fossa of bladder and rectum, separate and cut the ligaments and connective tissues linking the uterus at the front, back and both sides; remove the fatty tissues around the main ligaments and cut them near the pelvic wall; after all the paravaginal connective tissues are removed, the vagina is removed. (5) For some patients with stage IIb cervical cancer, “ultra extensive hysterectomy + retroperitoneal lymph node dissection” is performed. Regional lymph node dissection is more extensive, and extensive hysterectomy is also more extensive. The former reaches up to the parietal abdominal aortic lymph nodes, while the latter requires dissection of the common trunk of the closed artery and vein, the intraskeletal artery and vein, the inferior gluteal artery and vein, and the pubic autonomic artery, and removal of the main ligament from its root where it attaches to the pelvic wall. Also, for a long time, many people think that everything will be fine and there will be no big problem after the surgery for early stage tumor patients. However, they do not know that it is already a hidden danger at this time. Even for early-stage tumors, if the pathological results after surgery suggest that there are high-risk factors for tumor recurrence, post-operative adjuvant radiotherapy and chemotherapy are the safe deposit box to ensure long-term survival of patients. Unfortunately, many obstetricians and gynecologists in primary hospitals have blind knowledge in this field and fail to advise patients to continue treatment, thus delaying the best time for treatment, resulting in recurrence and metastasis of tumor cells. Therefore, we call upon: tumor patients must go to regular and standardized tumor specialists for treatment at the first time after the disease is diagnosed, in order to ensure better efficacy of tumor treatment.